Scientific Publications


Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database

JCO Oncology Practice
Ray et al

Retrospective analysis of real‐world management of EGFR‐mutated advanced NSCLC, after first‐line EGFR‐TKI treatment: US treatment patterns, attrition,…

Drugs Real World Outcomes
Nieva J et al

Reaching beyond maximum grade: Progress and future directions for modernising the assessment and reporting of adverse events in haematological maligna…

The Lancet Haematology
Thanarajasingam G et al.

Cancer registry data linkage of electronic health record data from ASCO’s CancerLinQ: Evaluation of advantages, limitations, and lessons learned

JCO Clinical Cancer Informatics
Charlton et al.

Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a Cance…

Breast Cancer Research and Treatment
Miller et al.

Quantitating and Assessing Interoperability Between Electronic Health Records

Journal of the American Medical Informatics Association
Bernstam et al.

The Chasm Between Cancer Quality Measures and EHR Data Quality

JCO Clinical Cancer Informatics
Schorer et al.

The Friends of Cancer Research real-world data collaboration pilot 2.0: Methodological recommendations from oncology case studies

Clinical Pharmacology & Therapeutics
Rivera et a.

Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach

Journal for Immunotherapy of Cancer
Heilbroner et al.


Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data

2022 World Conference on Lung Cancer
Behera M et al

Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients

ASCO 2022 Annual Meeting
Lal LS

Characterizing node-negative non-small cell lung cancer patients with similarity networks: A CancerLinQ Discovery analysis

ASCO 2022 Annual Meeting
Moen EL

Impact of trial site selection on minority patient recruitment in prostate cancer trials

ASCO 2022 Annual Meeting
Lagor C

Natural language processing-optimized case selection for real world evidence studies

ASCO 2022 Annual Meeting
Koskimaki J

Identifying genetic factors of response and resistance to CDK4/6 inhibitors in metastatic HR+/HER2- breast cancer using real-world data

ASCO 2022 Annual Meeting
Agrawal S

Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): an analysis of CancerLinQ…

ASCO 2022 Annual Meeting
Mileham KF

Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials

ASCO 2022 Annual Meeting
Bhandari S

Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data

ASCO 2022 Annual Meeting

Behera M